Guggenheim Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

Guggenheim Capital’s Portfolio AMLX Stock Details AMLX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$355K	Buy
2025 Q4	$305K	Buy
2025 Q3	$338K	Sell
2025 Q2	$229K	Sell
2025 Q1	$134K	Buy
2024 Q4	$136K	Buy
2024 Q3	$49.9K	Sell
2024 Q2	$29.4K	Sell
2024 Q1	$46.4K	Buy
2023 Q4	$220K	Buy